tiprankstipranks
Cell Source Inc (CLCS)
OTHER OTC:CLCS
US Market

Cell Source (CLCS) Financial Statements

8 Followers

Cell Source Financial Overview

Cell Source's market cap is currently ―. The company's EPS TTM is $-0.173; its P/E ratio is -2.29; Cell Source is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -4.74M$ -995.38K$ -497.96K$ -1.08M-
EBITDA$ -4.74M$ -995.38K-$ -936.80K-
Net Income Common Stockholders$ -1.37M$ -1.65M$ -1.54M$ -1.99M-
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 22.20K$ 2.58K$ 21.99K$ 133.01K$ 222.66K
Total Assets$ 195.17K$ 248.36K$ 362.33K$ 232.42K$ 409.85K
Total Debt$ 42.03K$ 130.04K$ 321.50K$ 0.00$ 1.83M
Net Debt$ 19.83K$ 127.46K$ 299.51K$ -133.01K$ 1.60M
Total Liabilities$ 2.53M$ 16.28M$ 15.31M$ 14.45M$ 13.04M
Stockholders Equity$ -15.61M$ -16.03M$ -14.95M$ -14.22M$ -12.63M
Cash Flow-
Free Cash Flow$ -722.29K$ -279.60K-$ -310.05K-
Operating Cash Flow$ -722.29K$ -279.60K$ -1.04M$ -310.05K-
Investing Cash Flow-----
Financing Cash Flow$ 741.91K$ 260.56K$ 925.00K$ 219.96K-
Currency in USD

Cell Source Earnings and Revenue History

Cell Source Debt to Assets

Cell Source Cash Flow

Cell Source Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis